Method
Level · gp.fundamentals.debt_to_revenue
Raw value 11.29% · OPTIONAL
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTVivos Therapeutics, Inc.'s latest supported as-filed period reports revenue of $5.2M, 34.9% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 11.29% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 8.07% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -61.09% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 34.90% · CORE
Level · gp.fundamentals.gross_margin
Raw value 57.31% · CORE
Level · gp.fundamentals.operating_margin
Raw value -93.63% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 1.94% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 34.9%; Operating margin moved 3372 bp higher; Operating income increased 0.8%.
3 evidence-backed componentsShares outstanding changed +168.1% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
VVOS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-041807SEC ↗8-KSep 8, 2026Period Aug 31, 20260001493152-26-041616SEC ↗4Aug 26, 2026Period Jul 31, 20260001493152-26-040238SEC ↗8-KAug 21, 2026Period Aug 20, 20260001493152-26-039736SEC ↗10-QAug 14, 2026Period Jun 30, 20260001493152-26-038336SEC ↗8-KAug 11, 2026Period Aug 5, 20260001493152-26-037173SEC ↗8-KAug 3, 2026Period Jul 31, 20260001493152-26-035867SEC ↗4Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 31, 2026Filed Aug 26, 2026 | Amman Bradford K.Principal Accounting Officer | Grant Or AwardDirect | 250,000 | $0 | $102,500 | Form 4 ↗ |
| Jul 31, 2026Filed Aug 26, 2026 | Amman Bradford K.Principal Accounting Officer | Grant Or AwardDirect | 150,000 | $0 | $61,500 | Form 4 ↗ |
| Jun 30, 2026Filed Jul 15, 2026 | Skaff Michael CReporting owner | Open Market PurchaseIndirect | 859,166 | $1 | $500,035 | Form 4 ↗ |
| Jun 30, 2026Filed Jul 15, 2026 | Skaff Michael CReporting owner | Open Market PurchaseIndirect | 1,890,164 | $1 | $1.1M | Form 4 ↗ |
| Jun 30, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Revenue changed +34.9% from the comparable as-filed period.
Free-cash-flow proxy changed +16.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital changed -5421.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Operating margin changed +3372 basis points from the comparable as-filed period.
Cash & equivalents changed -59.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital / assets changed -6817 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-304815| Skaff Michael CReporting owner |
| Open Market PurchaseIndirect |
| 2,749,330 |
| $1 |
| $1.6M |
| Form 4 ↗ |